Cardium Therapeutics
San Diego
About Cardium Therapeutics
Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to partnering, commercialization and other economic monetizations. Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing and cardiovascular indications, and the To Go Brands nutraceutical supplement business.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $750.0K
- Funding stage: IPO
- Last round: Post-IPO Debt (Jun 2009)
- Ticker: otcpink:CRXM
- Website: cardiumthx.com
- Phone: 8584361001
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cardium-therapeutics-1123301 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.